|
E-HEALTHCARE: FUTURE & PRESENT
The internet is changing the way the pharmaceutical industry communicates with its regulators, doctors and importantly its patients. We are moving to a shared space, an increasingly transparent dialogue between all stakeholders. What will these changes mean for the pharmaceutical industry?
The move to E-Healthcare raises questions on: levels of transparency, compliance, e-marketing, risk management, information tailored to the lay public, online data registries (EudraCT), relationship management with key stakeholders, and much more.
What will the impact be on Medical Affairs? What are the pros and cons? What is the best way forward in this new e-context? What are the opportunities and pitfalls?
The future is here and now – are you prepared for it?
Not only will the e-impact on drug development processes be explored. BeAPP aims to expand the scope to the broader pharmaceutical setting in collaboration with Pharma.be. With the help of other associations such as Pharma.be, ACRP, VAPI-UPIP, BRAS, Aresa all these questions and many more will be dealt with. The e-healthcare age is already upon us and must be incorporated in the life science industry swiftly.
On these questions and many more BeAPP will try to find an answer and/or provide an overview.
|